Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
BMJ Open|June 6, 2014
Environments, risk and health harms: a qualitative investigation into the illicit use of anabolic steroids among people using harm reduction services in the UKAndreas Kimergård, Jim McVeigh
Harm Reduction Journal|July 3, 2014
Variability and dilemmas in harm reduction for anabolic steroid users in the UK: a multi-area interview studyAndreas Kimergård, Jim McVeigh
Accountability in Research|March 9, 2021
A critical analysis of respondent quotes used as titles of qualitative research papers that are published in peer-reviewed journalsStephen Parkin, Andreas Kimergård
Drug Testing and Analysis|April 1, 2010
Elephant in the room? The methodological implications for public health research of performance-enhancing drugs derived from the illicit marketMichael Evans-Brown, Andreas Kimergård, Jim McVeigh
JMIR Mhealth and Uhealth|December 15, 2018
Developing Typologies of User Engagement With the BRANCH Alcohol-Harm Reduction Smartphone App: Qualitative StudyJoanna Milward, Paolo Deluca, Colin Drummond, et al.
Human Psychopharmacology|June 16, 2017
A market on both "sides" of the law: The use of the hidden web for the sale of new psychoactive substancesElle Wadsworth, Colin Drummond, Andreas Kimergård, et al.
Frontiers in Psychiatry|April 19, 2021
The Severity of Dependence Scale (SDS) for Codeine: Preliminary Investigation of the Psychometric Properties of the SDS in an Online Sample of Codeine Users From the UKPaolo Deluca, Michelle Foley, Jacklyn Dunne, et al.
Pain and Therapy|June 14, 2016
How Resistant to Tampering are Codeine Containing Analgesics on the Market? Assessing the Potential for Opioid ExtractionAndreas Kimergård, Paolo Deluca, Peter Hindersson, et al.
BMJ Open|July 5, 2022
Prevalence of anabolic steroid users seeking support from physicians: a systematic review and meta-analysisJulio Mario Xerfan Amaral, Andreas Kimergård, Paolo Deluca
Drug Testing and Analysis|August 2, 2016
Identification of a new psychoactive substance in seized material: the synthetic opioid N-phenyl-N-[1-(2-phenethyl)piperidin-4-yl]prop-2-enamide (Acrylfentanyl)Torben Breindahl, Andreas Kimergård, Mette Findal Andreasen, et al.
Pageof 3